Chronic obstructive arteriopathy: in addition to the endovascular method, the use of autologous mononuclear cells is gaining ground in the field of angiogenic treatments.

Critical ischaemia of the lower limb and the use of mononuclear cells from peripheral blood in endovascular revascularisation and non-revascularisable patients: recent studies confirm a reduction in major amputations, greater and faster healing of trophic lesions, reduction and disappearance of pain and improved peripheral oxygenation. Article by Dr Massimiliano Walter Guerrieri